Compare · DFTX vs PAVS
DFTX vs PAVS
Side-by-side comparison of Definium Therapeutics Inc. (DFTX) and Paranovus Entertainment Technology Ltd. (PAVS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both DFTX and PAVS operate in Medicinal Chemicals and Botanical Products (Health Care), so they compete in similar markets.
- DFTX is the larger of the two at $4.83B, about 2302.6x PAVS ($2.1M).
- DFTX has been more active in the news (29 items in the past 4 weeks vs 2 for PAVS).
- DFTX has more recent analyst coverage (5 ratings vs 0 for PAVS).
- Company
- Definium Therapeutics Inc.
- Paranovus Entertainment Technology Ltd.
- Price
- -
- -
- Market cap
- $4.83B
- $2.1M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medicinal Chemicals and Botanical Products
- Medicinal Chemicals and Botanical Products
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2019
- News (4w)
- 29
- 2
- Recent ratings
- 5
- 0
Latest DFTX
- Big Pharma Just Paid Up to $3.8 Billion for Psychedelic Medicine, and the Rest of the Sector Is Being Repriced in Real Time
- Definium Therapeutics Launches Wired for Worry, a Health Care Provider Initiative to Advance the Understanding of Generalized Anxiety Disorder (GAD) Patient Impact and Neurobiology
- New Healthcare Claims Study Published in CNS Spectrums Finds High Rates of Treatment Switching, Discontinuation, and Prolonged Gaps in Care Among Patients with Generalized Anxiety Disorder (GAD)
- Definium Therapeutics Announces New Employee Inducement Grants
- Multi-Billion-Dollar Battle for the Future of Depression Treatment Has Begun Creating a Huge Opportunity
- Chief Legal Officer Sullivan Mark sold $585,750 worth of shares (13,008 units at $45.03) as part of a pre-agreed trading plan, decreasing direct ownership by 4% to 320,571 units (SEC Form 4) (withholding tax)
- Chief Medical Officer Karlin Daniel sold $451,876 worth of shares (10,035 units at $45.03) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 503,282 units (SEC Form 4) (withholding obligation)
- Chief Financial Officer Roberts Brandi sold $135,675 worth of shares (3,013 units at $45.03) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 209,487 units (SEC Form 4) (withholding obligation)
- Chief Executive Officer Barrow Robert sold $1,315,236 worth of shares (29,208 units at $45.03) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 1,098,246 units (SEC Form 4) to satisfy withholding obligation
- Chief Commercial Officer Wiley Matthew T. sold $129,101 worth of shares (2,867 units at $45.03) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 174,633 units (SEC Form 4) (withholding obligation)
Latest PAVS
- SEC Form 6-K filed by Paranovus Entertainment Technology Ltd.
- Paranovus Entertainment Technology Limited Announces 1-For-100 Reverse Share Split
- SEC Form 6-K filed by Paranovus Entertainment Technology Ltd.
- SEC Form 424B5 filed by Paranovus Entertainment Technology Ltd.
- PAVS Announces Pricing of a $10 Million Registered Direct Offering of Class A Ordinary Shares and Pre-Funded Warrants
- Beyond Fast Fashion: Advanced Fibers and Smart Manufacturing Are Reshaping the Global Textile Industry
- SEC Form 6-K filed by Paranovus Entertainment Technology Ltd.
- PAVS Announces Termination of the Sales Agreement for its At-the-Market Offering with AC Sunshine Securities
- Paranovus Entertainment Technology Limited Signs Non-Binding Letter of Intent to Acquire Jabanero Inc.
- SEC Form 6-K filed by Paranovus Entertainment Technology Ltd.